Evidence map›Paper›PMID 34168208›Full record

ArticleScientific reports2021

Exoproteomic analysis of two MLST clade 2 strains of Clostridioides difficile from Latin America reveal close similarities.

Dvison de Melo Pacífico, Cecília Leite Costa, Hercules Moura, John R Barr, Guilherme Augusto Maia, Vilmar Benetti Filho, Renato Simões Moreira, Glauber Wagner, Regina Maria Cavalcanti Pilotto Domingues, Carlos Quesada-Gómez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Comparative biofilm-forming ability betweenFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Dvison de Melo Pacífico *Department of Morphology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, 60430-170, Brazil.
Cecília Leite Costa *Department of Morphology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, 60430-170, Brazil.
Hercules MouraDivision of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA, USA.
John R BarrDivision of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Guilherme Augusto MaiaMicrobiology, Immunology and Parasitology Department, Laboratory of Bioinformatics, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Vilmar Benetti FilhoMicrobiology, Immunology and Parasitology Department, Laboratory of Bioinformatics, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Renato Simões MoreiraMicrobiology, Immunology and Parasitology Department, Laboratory of Bioinformatics, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Glauber WagnerMicrobiology, Immunology and Parasitology Department, Laboratory of Bioinformatics, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Regina Maria Cavalcanti Pilotto DominguesInstitute of Microbiology Paulo de Góes, Laboratory of Anaerobic Biology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Carlos Quesada-GómezFacultad de Microbiología and Centro de Investigación en Enfermedades Tropicales, Universidad de Costa Rica, San José, Costa Rica.
Eliane de Oliveira FerreiraInstitute of Microbiology Paulo de Góes, Laboratory of Anaerobic Biology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Gerly Anne de Castro BritoDepartment of Morphology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, 60430-170, Brazil. gerlybrito@hotmail.com.
Universidade Federal de Santa Catarina · BRUniversidade Federal do Ceará · BRCenters for Disease Control and Prevention · USUniversidade Federal do Rio de Janeiro · BRUniversidad de Costa Rica · CR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridioides difficile BI/NAP1/ribotype 027 is an epidemic hypervirulent strain found worldwide, including in Latin America. We examined the genomes and exoproteomes of two multilocus sequence type (MLST) clade 2 C. difficile strains considered hypervirulent: ICC-45 (ribotype SLO231/UK[CE]821), isolated in Brazil, and NAP1/027/ST01 (LIBA5756), isolated during a 2010 outbreak in Costa Rica. C. difficile isolates were cultured and extracellular proteins were analyzed using high-performance liquid chromatography-tandem mass spectrometry. Genomic analysis revealed that these isolates shared most of the gene composition. Only 83 and 290 NAP1/027 genes were considered singletons in ICC-45 and NAP1/027, respectively. Exoproteome analysis revealed 197 proteins, of which 192 were similar in both strains. Only five proteins were exclusive to the ICC-45 strain. These proteins were involved with catalytic and binding functions and indirectly interacted with proteins related to pathogenicity. Most proteins, including TcdA, TcdB, flagellin subunit, and cell surface protein, were overrepresented in the ICC-45 strain; 14 proteins, including mature S-layer protein, were present in higher proportions in LIBA5756. Data are available via ProteomeXchange with identifier PXD026218. These data show close similarity between the genome and proteins in the supernatant of two strains with hypervirulent features isolated in Latin America and underscore the importance of epidemiological surveillance of the transmission and emergence of new strains.

Indexed as

Multilocus Sequence TypingClostridioides difficileClostridium InfectionsDisease OutbreaksHumansLatin AmericaPhylogenyProteomicsRibotyping

Identifiers

PMID34168208
PMCPMC8225638
OpenAlexW3174013280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.